Emmessar Biotech&Nut - Quaterly Results

04 Feb 2023 Evaluate
The total revenue hovered 166.87% to Rs. 4.27 millions for the December 2022 quarter as against Rs. 1.60 millions during the corresponding quarter last year.The Net Loss for the quarter ended December 2022 is Rs. -0.23 millions as compared to Net Profit of Rs. 1.69 millions of corresponding quarter ended December 2021Operating profit for the quarter ended December 2022 rose to 2.73 millions as compared to 1.92 millions of corresponding quarter ended December 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 4.27 1.60 166.87 7.03 2.19 221.00 3.65 69.91 -94.78
Other Income 4.45 4.08 9.07 13.18 12.13 8.66 19.19 14.66 30.90
PBIDT 2.73 1.92 42.19 7.89 4.95 59.39 10.25 23.12 -55.67
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 2.73 1.92 42.19 7.89 4.95 59.39 10.25 23.12 -55.67
Depreciation 0.24 0.23 4.35 0.70 0.55 27.27 0.92 0.58 58.62
PBT 2.49 1.69 47.34 7.19 4.40 63.41 9.33 22.54 -58.61
TAX 2.72 0.00 0.00 4.12 0.00 0.00 4.57 8.05 -43.23
Deferred Tax 1.72 0.00 0.00 2.12 0.00 0.00 0.22 4.48 -95.09
PAT -0.23 1.69 -113.61 3.07 4.40 -30.23 4.76 14.49 -67.15
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 63.93 120.00 -46.72 112.23 226.03 -50.35 280.82 33.07 749.15

Emmessar Biotech&Nut Share Price

43.83 1.54 (3.64%)
29-Apr-2024 14:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1517.80
Dr. Reddys Lab 6262.80
Cipla 1403.15
Zydus Lifesciences 957.20
Lupin 1633.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.